# Premarket Notification [510(k)] Summary

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92 The assigned 510(k) number is : k062737

# Company:

Horiba ABX   
Parc Euromédecine   
Rue du Caducée - BP 7290   
34184 Montpellier cedex 4   
FRANCE   
Telephone: + (33) 4 67 14 15 03   
Fax: $^ +$ (33) 4 67 14 15 17

Contact Person: Pascal Macziola (pmacziola@fr.abx. fr)

Date Prepared: $2 4 ^ { \mathrm { t h } }$ April 2007

# Device Names:

The following reagents, controls & calibrators are for use in conjunction with the ABX PENTRA 400, cleared to market under K052007.

# REAGENTS :

# ABX PENTRA CK NAC CP

Trade/Proprietary Name: Common or Usual Name: Device Class Classification Name:

Total Creatine khnase   
Class II   
$\ S 8 6 2 . 1 2 1 5$ : Creatine Phosphokinase/Creatine kinase or isoenzymes   
Test System   
CGS ; Nad reduction/Nadh oxidation, Cpk or isoenzymes

Product Code:

# ABX PENTRA Myoglobin CP

Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:   
Myoglobin   
Class II   
$\ S 8 6 6 . 5 6 8 0$ : Myoglobin immunological Test System   
DDR ; Myoglobin, antigen, antiserum, control

# CALIBRATORS:

Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:

# ABX PENTRA Myoglobin Cal

Myoglobin Calibrator Class II $\ S 8 6 2 . 1 1 5 0$ : Calibrator JIT ; Calibrator, Secondary

# ABX PENTRA Multical (K060854)

Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:   
Multical   
Class II   
$\ S 8 6 2 . 1 1 5 0$ : Calibrator   
JIX ; Calibrator, Multi-Analyte Mixture

# ABX PENTRA CK Control

CONTROLS :   
Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:   
CK Control   
Class I   
$\ S 8 6 2 . 1 6 6 0 :$ Quality control material (assayed)   
JJY ; Multi-Analyte Controls, All Kinds (Assayed)

# ABX PENTRA Immuno II Control L/H

Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:   
Control Low/High   
Class I   
$\ S 8 6 2 . 1 6 6 0 :$ Quality control material (assayed)   
JJY ; Multi-Analyte Controls, All Kinds (Assayed)   
Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:

# ABX PENTRA N Control (K060854)

N Control   
Class I   
$\ S 8 6 2 . 1 6 6 0 :$ Quality control material (assayed)   
JY ; Multi-Analyte Controls, All Kinds (Assayed)

# ABX PENTRA P Control (K060854)

Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:   
P Control   
Class I   
$\ S 8 6 2 . 1 6 6 0$ : Quality control material (assayed)   
JJY ; Multi-Analyte Controls, All Kinds (assayed)

# Substantial Equivalence:

The data and information supplied in this submission demonstrates substantial equivalence to their respective predicate devices :

<table><tr><td rowspan=1 colspan=1>Submission device</td><td rowspan=1 colspan=1>Substantially equivalentPredicate device</td></tr><tr><td rowspan=1 colspan=1>ABX PENTRA CK NAC CP</td><td rowspan=1 colspan=1>K834502</td></tr><tr><td rowspan=1 colspan=1>ABX PENTRA Myoglobin CP</td><td rowspan=1 colspan=1>K021229</td></tr><tr><td></td><td></td></tr><tr><td rowspan=1 colspan=1>ABX PENTRA Myoglobin Cal</td><td rowspan=1 colspan=1>K021229</td></tr><tr><td rowspan=1 colspan=1>ABX PENTRA Multical</td><td rowspan=1 colspan=1>K060854</td></tr><tr><td></td><td></td></tr><tr><td rowspan=1 colspan=1>ABX PENTRA CK Control</td><td rowspan=1 colspan=1>K954074</td></tr><tr><td rowspan=1 colspan=1>ABX PENTRA Immuno II ControlL/H</td><td rowspan=1 colspan=1>K961828</td></tr><tr><td rowspan=1 colspan=1>ABX PENTRA N Control</td><td rowspan=1 colspan=1>K060854</td></tr><tr><td rowspan=1 colspan=1>ABX PENTRA P Control</td><td rowspan=1 colspan=1>K060854</td></tr></table>

# Description:

All the reagents, controls and calibrators included in this submission are for use on the ABX PENTRA 400 (K052007), which is a discrete photometric benchtop clinical chemistry analyzer.

The ABX PENTRA CK NAC CP is an in vitro diagnostic assay for the quantitative determination of total creatine kinase in human serum and plasma based on an optimized UV test. The assay is composed of a bi-reagent cassette, with $2 6 \mathrm { m l }$ and $6 . 5 { \mathrm { ~ m l } }$ compartments. Reagents are chemical solutions with additives.

The ABX PENTRA Myoglobin CP is an in vitro diagnostic assay for the quantitative determination of myoglobin in human serum and plasma based on a latex-enhanced immunoturbidimetric test. The assay is composed of a bi-reagent cassette, with $1 5 \mathrm { m l }$ and $9 . 5 ~ \mathrm { { m l } }$ compartments. Reagents are chemical solutions with chemical additives and substances of animal origin.

The ABX PENTRA Myoglobin Cal is a liquid calibrator prepared from a dilution of purified myoglobin positive human sera. It is used for the calibration of the myoglobin assay. The assigned values are given on the vials. This calibrator is provided in five vials of $1 \mathrm { m l }$ .

The ABX PENTRA CK Control is a lyophilized assayed control prepared from a bovine serum albumin with chemical additives and material of biological origin. It has to be used for the quality control of the creatine kinase assay. The assigned values are given in the cnclosed annex. This calibrator is provided in 4 vials of $3 \ \mathfrak { i n } \mathfrak { k }$ .

The ABX PENTRA Immuno II Control L/H is a lyophilized assayed control prepared from a stabilized pool of human sera. It has 2 levels ( Low and High) to be used for the quality control of the myoglobin assay. The assigned values are given in the enclosed annex. Each level of this control is provided in one vial of $\beta \underset { \mathfrak { s s a s } } { \mathrm { \ G r } } |$ .

The ABX PENTRA Multical is a lyophilized human serum calibrator with chemical additives and materials of biological origin. The assigned values of the calibrator components are given in the enclosed annex, ensuring optimal calibration of the appropriate HORIBA ABX methods on the ABX PENTRA 400 analyzer. This calibrator is provided in ten vials of $3 \mathrm { m l }$ .

The ABX PENTRA N Control and ABX PENTRA P Control are quality control products consisting of lyophilized human serum with chemical additives and materials of biological origin added as required to obtain given component levels. The assigned values of the control components are given in the enclosed annexes, ensuring control of the appropriate HORIBA ABX methods on the ABX PENTRA 400 analyzer. Each control is provided in ten vials of $5 \mathrm { m l }$ .

# Intended Use :

All reagents in this submission are intended for use on the ABX PENTRA 400 for the quantitative in-vitro determination of their respective analytes : Total Creatine Kinase and Myoglobin using human serum and plasma.

The controls and calibrators are intended for use in association with the above reagents.

# Discussion of Performance Data:

<table><tr><td colspan="2">ABX PENTRA CK NAC CP :</td></tr><tr><td>Sample type</td><td>Serum &amp; plasma</td></tr><tr><td>Detection limit</td><td>8 U/</td></tr><tr><td>Accuracy and Precision</td><td>CV Total &lt; 4.65%</td></tr><tr><td>Measuring range</td><td>8 UA1 - 1500 0A</td></tr><tr><td>Upper linearity limit</td><td>1500 U/1. and with automatic post-dilution : 4500 U/l</td></tr><tr><td>Correlation (n=350)</td><td>Y = 1.05 x - 1.75 with a correlation coefficient r2 = 0.9930.</td></tr><tr><td>Calibration stability</td><td>8 days</td></tr><tr><td>Reagent stability</td><td>closed stability: 18 months at 2-8°C on-board stability (refrigerated area): 64 days</td></tr></table>

# ABX PENTRA Myoglobin CP :

<table><tr><td>Sample type</td><td>Serum &amp; plasma</td></tr><tr><td>Detection limit</td><td>6.7 μg/1</td></tr><tr><td>Accuracy and Precision</td><td>CV Total &lt; 5.24%</td></tr><tr><td>Measuring range</td><td>20.7 μg/l  500 μg/</td></tr><tr><td>Upper linearity limit</td><td>500 μg/1</td></tr><tr><td>Correlation (n180)</td><td>Y = 0.94 x + 19.44 with a correlation coefficient r2 = 0.9756.</td></tr><tr><td>Calibration stability</td><td>21 days</td></tr><tr><td>Reagent stability</td><td>closed stability: 12 months at 2-8°C on-board stability (refrigerated area): 35 days</td></tr><tr><td colspan="2">ABX PENTRA Myoglobin Cal:</td></tr><tr><td>Analytes</td><td>Myoglobin</td></tr><tr><td>Format</td><td>Liquid preparation of diluted purified myoglobin positive human sera : 5 levels</td></tr><tr><td>Stability</td><td>Closed stability: 12 months at 2°C to 10°C</td></tr><tr><td></td><td>Open stability: 7 weeks at 2°C to 10°C</td></tr></table>

<table><tr><td rowspan=1 colspan=3>ABX PENTRA Multical:</td></tr><tr><td rowspan=1 colspan=1>Analytes</td><td rowspan=1 colspan=1>Already cleared</td><td rowspan=1 colspan=1>Included in this submission</td></tr><tr><td rowspan=1 colspan=1>Alkaline phosphatase</td><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Alanine aminotransferase</td><td rowspan=1 colspan=1>(CLIA)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Amylase</td><td rowspan=1 colspan=1>(K062180)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Aspartate aminotransferase</td><td rowspan=1 colspan=1>(K060318)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Creatine kinase</td><td rowspan=1 colspan=1>canmaGlo</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>GGT</td><td rowspan=1 colspan=1>(CLIA)</td><td rowspan=1 colspan=1>cYanmaGntaYllowb</td></tr><tr><td rowspan=1 colspan=1>Lipase</td><td rowspan=1 colspan=1>(CLIA)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Albumin*</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Direct Bilirubin</td><td rowspan=1 colspan=1>(K060325)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Total Bilirubin</td><td rowspan=1 colspan=1>(K060325)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Calcium</td><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Cholesterol</td><td rowspan=1 colspan=1>(K060854)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Glucose HK</td><td rowspan=1 colspan=1>(K052007)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Glucose PAP</td><td rowspan=1 colspan=1>(K052007)</td><td rowspan=1 colspan=1>cYanmaelowb</td></tr><tr><td rowspan=1 colspan=1>Iron</td><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Lactic acid</td><td rowspan=1 colspan=1>(CLIA)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Magnesium</td><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Phosphorus</td><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Total Protein*</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Triglycerides</td><td rowspan=1 colspan=1>(K060854)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Urea / Blood Urea Nitrogen</td><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Uric acid</td><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=3>...</td></tr></table>

<table><tr><td>Format</td><td>Lyophilized human serum with chemical additives and materials of biological origin</td></tr><tr><td>Stability</td><td>Closed stability: 24 months at 2-8°C Open stability:</td></tr><tr><td></td><td>Once opened, the calibrator components** are stable for :</td></tr><tr><td></td><td>8 hours at 15°C to 25°C</td></tr><tr><td></td><td>2 days at 2°C to 8°C</td></tr><tr><td></td><td>2 weeks at -25°C to −15°C</td></tr><tr><td></td><td>**Exceptions</td></tr><tr><td></td><td>Direct Bilirubin</td></tr><tr><td></td><td>3 hours at 15°C to 25°C</td></tr><tr><td></td><td>8 hours at 2°C to 8°C</td></tr><tr><td></td><td>2 weeks at -25°C to −15°C</td></tr><tr><td></td><td>Total Bilirubin</td></tr><tr><td></td><td>6 hours at 15°C to 25°C</td></tr><tr><td></td><td>1 day at 2°C to 8°C</td></tr><tr><td></td><td>2 weeks at 25°C to -15°C</td></tr></table>

\* Not cleared as of date of submission

# CONTROLS

<table><tr><td colspan="2">ABX PENTRA CK Control:</td></tr><tr><td>Analytes</td><td>Total Creatine Kinase</td></tr><tr><td>Format</td><td>Lyophilized preparation of bovine serum albumin with chemical additives and material of animal origin</td></tr><tr><td>Stability</td><td>Closed stability: 18 months at 2°C to 8°C Open stability: 24 hours at 15°C to 25°C</td></tr></table>

ABX PENTRA Immuno II Control L/H:   

<table><tr><td>Analytes Format</td><td>Myoglobin</td></tr><tr><td></td><td>Lyophilized preparation of bovine serum albumin with chemical additives and material of animal origin</td></tr><tr><td>Stability</td><td>Closed stability: 18 months at 2°C to 10°C Open stability: 2 weeks at 2°C to 10°C</td></tr></table>

<table><tr><td rowspan=1 colspan=9>ABX PENTRA N Control:</td></tr><tr><td rowspan=1 colspan=7>Analytes</td><td rowspan=1 colspan=1>Already cleared</td><td rowspan=1 colspan=1>Included in this submission</td></tr><tr><td rowspan=2 colspan=7>Alkaline phosphataseAlanine aminotransferase</td><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1>Y</td></tr><tr><td rowspan=1 colspan=1>(CLIA)</td><td rowspan=1 colspan=1>Y</td></tr><tr><td rowspan=1 colspan=2></td><td rowspan=9 colspan=5>AmylaseAspartate aminotransferaseCreatine kinaseGGTLipaseAlbumin*Direct BilirubinTotal BilirubinCalcium</td><td rowspan=1 colspan=1>(K062180)</td><td rowspan=1 colspan=1>Y</td></tr><tr><td></td><td></td><td rowspan=1 colspan=1>(K060318)</td><td rowspan=1 colspan=1>Y</td></tr><tr><td></td><td></td><td rowspan=1 colspan=1>Y</td><td rowspan=1 colspan=1>Y</td></tr><tr><td></td><td></td><td rowspan=1 colspan=1>(CLIA)</td><td rowspan=1 colspan=1>Y</td></tr><tr><td></td><td></td><td rowspan=1 colspan=1>(CLIA)</td><td rowspan=1 colspan=1>Y</td></tr><tr><td></td><td></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td></td><td></td><td rowspan=1 colspan=1>(K060325)</td><td rowspan=1 colspan=1>Y</td></tr><tr><td></td><td></td><td rowspan=1 colspan=1>(K060325)</td><td rowspan=1 colspan=1>Y</td></tr><tr><td></td><td></td><td rowspan=1 colspan=3>Calcium</td><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1>Y</td></tr><tr><td rowspan=1 colspan=3></td><td rowspan=1 colspan=4>Chloride</td><td rowspan=1 colspan=1>Chloride</td><td rowspan=1 colspan=1>(K052007)</td></tr><tr><td rowspan=18 colspan=7>CholesterolHDLLDLCreatinineGlucose HKGlucose PAPIronLactic acidMagnesiumPhosphorusPotassiumSodiumTotal Protein*TriglyceridesUrea / Blood Urea NitrogenUric acid</td><td rowspan=1 colspan=1>Cholesterol</td><td rowspan=1 colspan=1>(K060854)</td></tr><tr><td rowspan=1 colspan=1>(K060854)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=6>LDL</td><td rowspan=1 colspan=1>(K060854)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=2></td><td rowspan=2 colspan=5>Creatinine</td><td rowspan=2 colspan=1>(K060205)</td><td rowspan=2 colspan=1>Y</td></tr><tr><td rowspan=1 colspan=2></td></tr><tr><td rowspan=1 colspan=1>(K052007)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>(K052007)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>(CLIA)</td><td rowspan=1 colspan=1>Y</td></tr><tr><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=2 colspan=2>Torus</td><td></td><td></td></tr><tr><td rowspan=1 colspan=1>orus</td><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=2>Potassium</td><td rowspan=1 colspan=1>(K052007)</td><td rowspan=1 colspan=1>Y</td></tr><tr><td rowspan=1 colspan=1>(K052007)</td><td rowspan=1 colspan=1>Y</td></tr><tr><td rowspan=1 colspan=1>E</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>(K060854)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=9>…</td></tr></table>

<table><tr><td>Format</td><td>Lyophilized human serum with chemical additives and materials of biological origin</td></tr><tr><td>Stability</td><td>Closed stability: 30 months at 2-8°C Open stability:</td></tr><tr><td></td><td>Once opened, the control components** are stable for :</td></tr><tr><td></td><td>12 hours at 15°C to 25°C</td></tr><tr><td></td><td>5 days at 2°C to 8°C</td></tr><tr><td></td><td>I month at -25°C to -15°C</td></tr><tr><td></td><td></td></tr><tr><td></td><td>**Exceptions</td></tr><tr><td></td><td>Direct Bilirubin</td></tr><tr><td></td><td>4 hours at 15°C to 25°C</td></tr><tr><td></td><td>8 hours at 2°C to 8°C</td></tr><tr><td></td><td>2 weeks at −25°C to -15°C</td></tr><tr><td></td><td>Total Bilirubin</td></tr><tr><td></td><td>8 hours at 15°C to 25°C</td></tr><tr><td></td><td>1 day at 2°C to 8°C</td></tr><tr><td></td><td>2 weeks at 25°C to -15°C</td></tr></table>

\* Not cleared as of date of submission

<table><tr><td rowspan=1 colspan=3>ABX PENTRA P Control:</td></tr><tr><td rowspan=1 colspan=1>Analytes</td><td rowspan=1 colspan=1>Already cleared</td><td rowspan=1 colspan=1>Included in this submission</td></tr><tr><td rowspan=1 colspan=1>Alkaline phosphatase</td><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Alanine aminotransferase</td><td rowspan=1 colspan=1>(CLIA)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Amylase</td><td rowspan=1 colspan=1>(K062180)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Aspartate aminotransferase</td><td rowspan=1 colspan=1>(K060318)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Creatine kinase</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>GGT</td><td rowspan=1 colspan=1>(CLIA)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Lipase</td><td rowspan=1 colspan=1>(CLIA)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Albumin*</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Direct Bilirubin</td><td rowspan=1 colspan=1>(K060325)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Total Bilirubin</td><td rowspan=1 colspan=1>(K060325)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Calcium</td><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Chloride</td><td rowspan=1 colspan=1>(K052007)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Cholesterol</td><td rowspan=1 colspan=1>(K060854)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>HDL</td><td rowspan=1 colspan=1>(K060854)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>LDL</td><td rowspan=1 colspan=1>(K060854)</td><td rowspan=1 colspan=1>EY</td></tr><tr><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Glucose HK</td><td rowspan=1 colspan=1>(K052007)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Glucose PAP</td><td rowspan=1 colspan=1>(K052007)</td><td rowspan=1 colspan=1>EY</td></tr><tr><td rowspan=1 colspan=1>Iron</td><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Lactic acid</td><td rowspan=1 colspan=1>(CLIA)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Magnesium</td><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1>EY</td></tr><tr><td rowspan=1 colspan=1>Phosphorus</td><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Potassium</td><td rowspan=1 colspan=1>(K052007)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Sodium</td><td rowspan=1 colspan=1>(K052007)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Total Protein*</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Triglycerides</td><td rowspan=1 colspan=1>(K060854)</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Urea / Blood Urea Nitrogen</td><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1>EY</td></tr><tr><td rowspan=1 colspan=1>Uric acid</td><td rowspan=1 colspan=1>(K060205)</td><td rowspan=1 colspan=1>EY</td></tr><tr><td rowspan=1 colspan=3>../...</td></tr></table>

<table><tr><td>Format</td><td>Lyophilized human serum with chemical additives and materials of biological origin</td></tr><tr><td>Stability</td><td>Closed stability: 30 months at 2-8°C</td></tr><tr><td></td><td>Open stability: Once opened, the control components** are stable for :</td></tr><tr><td></td><td></td></tr><tr><td></td><td>12 hours at 15°C to 25°C 5 days at 2°C to 8°C</td></tr><tr><td></td><td>1 month at -25°C to -15°C</td></tr><tr><td></td><td></td></tr><tr><td></td><td>**Exceptions Direct Bilirubin</td></tr><tr><td></td><td>4 hours at 15°C to 25°C</td></tr><tr><td></td><td>8 hours at 2°C to 8°C</td></tr><tr><td></td><td>2 weeks at −25°C to -15°C</td></tr><tr><td></td><td>Total Bilirubin</td></tr><tr><td></td><td>8 hours at 15°C to 25°C</td></tr><tr><td></td><td></td></tr><tr><td></td><td>1 day at 2°C to 8°C</td></tr><tr><td></td><td>2 weeks at -25°C to -15°C</td></tr></table>

\* Not cleared as of date of submission

# Conclusions for Performance Testing :

The performance testing data conclude that the safety and effectiveness of the devices are not compromised, and that they met all acceptance criteria, demonstrating that the devices are substantially equivalent to their respective predicate devices.

Horiba ABX   
c/o Pascal Macziola   
Regulatory Affairs Manager   
Parc Euromédecine   
Rue du Caducée - BP 7290   
34184 Montpellier cedex 4   
France

# JUN 1 2 2007

Re: k062737 Trade/Device Name: ABX Pentra CK NAC CP, ABX Pentra Myoglobin CP, ABX Pentra CK Control, ABX Pentra Immuno II Control L/H, ABX Pentra Myoglobin Cal, ABX Pentra N Control, ABX Pentra P Control, ABX Pentra Multical Regulation Number: 21 CFR $\ S 8 6 2 . 1 2 1 5$ EPY Regulation Name: Creatine phosphokinase/creatine kinase or isoenzymes test system. Regulatory Class: Class II Product Code: CGS, DDR, JIY, JIX, JIT Dated: April 25, 2007 Received: April 30, 2007

Dear Pascal Macziola:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with al the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2 -

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0490. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address at   
http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Jean M.Coopes, M.S. D.V.M. Jean M. Cooper, M.S., D.V.M.   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and   
Radiological Health

# Indications for Use

510(k) Number (if known):

Device Name: Cardiac Markers on ABX PENTRA 400 Clinical Chemistry Analyzer

Indications For Use:

Cardiac Markers reagents, with associated calibrators and controls, are intended for use on ABX PENTRA 400 Clinical Chemistry Analyzer to measure cardiac marker analytes.

ABX PENTRA CK-NAC CP reagent with associated calibrators and controls are for quantitative in vitro diagnostic determination of the total creatine kinase in human serum and plasma based on an optimized UV test.

Measurements of creatine phosphokinase and its isoenzymes are used in the diagnosis and treatment of myocardial infarction and muscle diseases such as progressive, Duchenne-type muscular dystrophy.

The ABX PENTRA CK Control is for use in quality control by monitoring accuracy and precision for the quantitative ABX PENTRA CK-MB RTU and ABX PENTRA CK-NAC methods.

Prescription Use X AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Conence RH, Offic In iDagnosti Devis OIVD Page 1 of _26

Carol Bena

e of In Vitro Diagnostic Device uation and Safety K062737

# Indications for Use

510(k) Number (if known):

Device Name: Cardiac Markers on ABX PENTRA 400 Clinical Chemistry Analyzer

Indications For Use:

ABX PENTRA Myoglobin CP reagent with associated calibrators and controls are for quantitative in vitro diagnostic determination of myoglobin (an oxygen storage protein found in muscle) in human serum and plasma based on a latex-enhanced immunoturbidimetric assay.

Measurements of myoglobin aids in the rapid diagnosis of heart or renal disease.

The ABX PENTRA Myoglobin Cal is a calibrator for use in the calibration of quantitative Horiba ABX PENTRA Myoglobin CP method on Horiba ABX clinical chemistry analyzers.

Carof Benen of In Vitro Diagnostic Device cation and Safety K062737

# Indications for Use

510(k) Number (if known):

Device Name: ABX PENTRA Immuno II Control L/H

Indications For Use:

The ABX PENTRA Immuno II Control L/H is for use in quality control by monitoring accuracy and precision.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF EEDED)

Cocence RHOffic  In ViDagosti Devis OVD Page3 of6 Caol C Benao

ce of In Vitro Diagnostic Device aluation and Safety $K 0 6 2 7 3 7$

# Indications for Use

510(k) Number (if known):

Device Name: ABX PENTRA Multical

Indications For Use:

The ABX PENTRA Multical is a calibrator for use in the calibration of quantitative Horiba ABX methods on Horiba ABX clinical chemistry analyzers.

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Canl Bemern

of In Vitro Diagnostic Device stion and Safety K062737

Pagel4of6

# Indications for Use

510(k) Number (if known):

Device Name: ABX PENTRA N Control

Indications For Use:

The ABX PENTRA N Control is for use in quality control by monitoring accuracy and precision.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Caol Bera

of In Vitro Diagnostic Device stion and Safety

Page.5 of 6

K062737

# Indications for Use

510(k) Number (if known):

Device Name: ABX PENTRA P Control

Indications For Use:

The ABX PENTRA P Control is for use in quality control by monitoring accuracy and precision.

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Caol Bener

Page bof 6

of In Vitro Diagnostic Device Instion and Safety K06 2737